As before, assume we have collected cross-sectional data about Alzheimer’s disease and CSF-tau concentration in a new population C. Using population C data, we can develop another simple diagnostic clinical risk prediction model to predict Alzheimer’s disease using logistic regression. This evidence concerns the gene MAPT and Alzheimer disease.